Insider Transactions Reported by 27 Insiders of Cullinan Therapeutics, Inc.

Symbol
CGEM on Nasdaq
Location
Cambridge, MA

Insiders trading volume in the past year

Cullinan Therapeutics, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Ansbert Gadicke Director $102,717,212 22 Jun 2022
UBS Oncology Impact Fund L.P. 10%+ Owner $95,297,419 16 Sep 2021
Lynx1 Capital Management LP 10%+ Owner $75,297,881 +$13,322,539 +21% 28 Oct 2025
Morana Jovan-Embiricos 10%+ Owner $56,397,201 24 Jun 2022
Vision SCS F2 10%+ Owner $55,775,322 02 Aug 2022
F2 Bioscience I 2017 Ltd 10%+ Owner $55,209,813 21 Jun 2022
NADIM AHMED President and CEO, Director $5,654,919 -$517,990 -8.4% 24 Feb 2026
Patrick Baeuerle Chief Scientific Officer $5,201,228 17 Feb 2023
Corrine Savill Chief Business Officer $3,014,785 18 Feb 2026
Jennifer Michaelson Chief Scientific Officer $2,472,294 -$450,477 -15% 25 Feb 2026
Thomas Ebeling Director $2,426,489 10 Jun 2024
Jeffrey Alan Jones Chief Medical Officer $2,314,736 -$178,948 -7.2% 24 Feb 2026
Jeffrey Trigilio Chief Financial Officer $2,166,809 22 Feb 2024
Jacquelyn Sumer Chief Legal Officer $1,853,447 -$136,724 -6.9% 24 Feb 2026
Mary Kay Fenton Chief Financial Officer $1,721,295 -$59,901 -3.4% 20 Feb 2026
Leigh Zawel Chief Scientific Officer, Small Molecules $869,521 11 Feb 2022
BVF PARTNERS L P/IL 10%+ Owner $799,446 19 Jan 2023
Keane Raymond T. Chief Legal Officer $300,585 11 Feb 2022
Nate Nguyen Interim PAO and PFO $216,408 29 Mar 2024
Mary Thistle Director 08 Aug 2024
Stephen W. Webster Director 12 Jun 2025
David D. Meek Director 12 Jun 2025
Anthony Rosenberg Director 12 Jun 2025
David P. Ryan Director 12 Jun 2025
Anne-Marie Martin Director 12 Jun 2025
Andrew R. Allen Director 07 Aug 2025
Mittie Doyle Director 07 Aug 2025

Recent Insider Transactions by Companies or Individuals for Cullinan Therapeutics, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.